nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—TLR9—PI3K Cascade—STK11—testicular cancer	0.00465	0.079	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—STK11—testicular cancer	0.00389	0.0661	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—STK11—testicular cancer	0.00378	0.0643	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—STK11—testicular cancer	0.00375	0.0637	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—STK11—testicular cancer	0.00365	0.062	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—STK11—testicular cancer	0.00365	0.062	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—FGFR3—testicular cancer	0.0032	0.0543	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—STK11—testicular cancer	0.00303	0.0515	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—FGFR3—testicular cancer	0.00267	0.0454	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—FGFR3—testicular cancer	0.0026	0.0442	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—FGFR3—testicular cancer	0.00258	0.0438	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—FGFR3—testicular cancer	0.00251	0.0426	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—FGFR3—testicular cancer	0.00251	0.0426	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—FGFR3—testicular cancer	0.00208	0.0354	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—BCL10—testicular cancer	0.00163	0.0277	CbGpPWpGaD
Hydroxychloroquine—Mood swings—Methotrexate—testicular cancer	0.0016	0.0017	CcSEcCtD
Hydroxychloroquine—Ataxia—Methotrexate—testicular cancer	0.00159	0.00169	CcSEcCtD
Hydroxychloroquine—Nausea—Chlorambucil—testicular cancer	0.00158	0.00168	CcSEcCtD
Hydroxychloroquine—Anaemia—Etoposide—testicular cancer	0.00157	0.00167	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00157	0.00167	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00157	0.00167	CcSEcCtD
Hydroxychloroquine—Somnolence—Ifosfamide—testicular cancer	0.00156	0.00166	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Methotrexate—testicular cancer	0.00156	0.00166	CcSEcCtD
Hydroxychloroquine—Affect lability—Epirubicin—testicular cancer	0.00156	0.00166	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00155	0.00165	CcSEcCtD
Hydroxychloroquine—Vomiting—Vinblastine—testicular cancer	0.00155	0.00165	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Doxorubicin—testicular cancer	0.00153	0.00163	CcSEcCtD
Hydroxychloroquine—Vertigo—Etoposide—testicular cancer	0.00153	0.00162	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Ifosfamide—testicular cancer	0.00153	0.00162	CcSEcCtD
Hydroxychloroquine—Headache—Vinblastine—testicular cancer	0.00153	0.00162	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00152	0.00162	CcSEcCtD
Hydroxychloroquine—Leukopenia—Etoposide—testicular cancer	0.00152	0.00162	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00152	0.00161	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dactinomycin—testicular cancer	0.00152	0.00161	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dactinomycin—testicular cancer	0.00152	0.00161	CcSEcCtD
Hydroxychloroquine—Fatigue—Ifosfamide—testicular cancer	0.00152	0.00161	CcSEcCtD
Hydroxychloroquine—Oedema—Cisplatin—testicular cancer	0.00152	0.00161	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Bleomycin—testicular cancer	0.00152	0.00161	CcSEcCtD
Hydroxychloroquine—Pain—Ifosfamide—testicular cancer	0.0015	0.0016	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Doxorubicin—testicular cancer	0.0015	0.0016	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Doxorubicin—testicular cancer	0.0015	0.0016	CcSEcCtD
Hydroxychloroquine—Mood swings—Epirubicin—testicular cancer	0.0015	0.00159	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Etoposide—testicular cancer	0.0015	0.00159	CcSEcCtD
Hydroxychloroquine—Ataxia—Epirubicin—testicular cancer	0.00149	0.00158	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Cisplatin—testicular cancer	0.00149	0.00158	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Cisplatin—testicular cancer	0.00148	0.00158	CcSEcCtD
Hydroxychloroquine—Asthenia—Bleomycin—testicular cancer	0.00148	0.00157	CcSEcCtD
Hydroxychloroquine—Convulsion—Etoposide—testicular cancer	0.00147	0.00157	CcSEcCtD
Hydroxychloroquine—Skin disorder—Cisplatin—testicular cancer	0.00147	0.00156	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Epirubicin—testicular cancer	0.00146	0.00155	CcSEcCtD
Hydroxychloroquine—Pruritus—Bleomycin—testicular cancer	0.00146	0.00155	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Methotrexate—testicular cancer	0.00145	0.00154	CcSEcCtD
Hydroxychloroquine—Nausea—Vinblastine—testicular cancer	0.00145	0.00154	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Epirubicin—testicular cancer	0.00145	0.00154	CcSEcCtD
Hydroxychloroquine—Anorexia—Cisplatin—testicular cancer	0.00145	0.00154	CcSEcCtD
Hydroxychloroquine—Affect lability—Doxorubicin—testicular cancer	0.00144	0.00153	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00144	0.00153	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00144	0.00153	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00143	0.00152	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Dactinomycin—testicular cancer	0.00141	0.0015	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Epirubicin—testicular cancer	0.0014	0.00148	CcSEcCtD
Hydroxychloroquine—Urticaria—Ifosfamide—testicular cancer	0.0014	0.00148	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Ifosfamide—testicular cancer	0.00139	0.00148	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Ifosfamide—testicular cancer	0.00139	0.00148	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Methotrexate—testicular cancer	0.00139	0.00148	CcSEcCtD
Hydroxychloroquine—Mood swings—Doxorubicin—testicular cancer	0.00139	0.00148	CcSEcCtD
Hydroxychloroquine—Ataxia—Doxorubicin—testicular cancer	0.00138	0.00146	CcSEcCtD
Hydroxychloroquine—Asthenia—Dactinomycin—testicular cancer	0.00138	0.00146	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Etoposide—testicular cancer	0.00136	0.00145	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Epirubicin—testicular cancer	0.00136	0.00144	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—testicular cancer	0.00135	0.00144	CcSEcCtD
Hydroxychloroquine—Skin disorder—Etoposide—testicular cancer	0.00135	0.00143	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—testicular cancer	0.00134	0.00142	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Methotrexate—testicular cancer	0.00134	0.00142	CcSEcCtD
Hydroxychloroquine—Anorexia—Etoposide—testicular cancer	0.00132	0.00141	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00132	0.0014	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Cisplatin—testicular cancer	0.00132	0.0014	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Dactinomycin—testicular cancer	0.00131	0.0014	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00131	0.00139	CcSEcCtD
Hydroxychloroquine—Vomiting—Bleomycin—testicular cancer	0.00131	0.00139	CcSEcCtD
Hydroxychloroquine—Drowsiness—Methotrexate—testicular cancer	0.0013	0.00139	CcSEcCtD
Hydroxychloroquine—Depression—Methotrexate—testicular cancer	0.0013	0.00138	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Epirubicin—testicular cancer	0.0013	0.00138	CcSEcCtD
Hydroxychloroquine—Rash—Bleomycin—testicular cancer	0.0013	0.00138	CcSEcCtD
Hydroxychloroquine—Pain—Cisplatin—testicular cancer	0.0013	0.00138	CcSEcCtD
Hydroxychloroquine—Dermatitis—Bleomycin—testicular cancer	0.0013	0.00138	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Ifosfamide—testicular cancer	0.0013	0.00138	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00129	0.00137	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Doxorubicin—testicular cancer	0.00129	0.00137	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—BCL10—testicular cancer	0.00129	0.0219	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Ifosfamide—testicular cancer	0.00126	0.00134	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Doxorubicin—testicular cancer	0.00125	0.00133	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Epirubicin—testicular cancer	0.00125	0.00133	CcSEcCtD
Hydroxychloroquine—Pruritus—Ifosfamide—testicular cancer	0.00124	0.00132	CcSEcCtD
Hydroxychloroquine—Weight decreased—Epirubicin—testicular cancer	0.00124	0.00132	CcSEcCtD
Hydroxychloroquine—Somnolence—Etoposide—testicular cancer	0.00123	0.00131	CcSEcCtD
Hydroxychloroquine—Nausea—Bleomycin—testicular cancer	0.00122	0.0013	CcSEcCtD
Hydroxychloroquine—Drowsiness—Epirubicin—testicular cancer	0.00122	0.0013	CcSEcCtD
Hydroxychloroquine—Vomiting—Dactinomycin—testicular cancer	0.00122	0.0013	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methotrexate—testicular cancer	0.00122	0.00129	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00121	0.00129	CcSEcCtD
Hydroxychloroquine—Rash—Dactinomycin—testicular cancer	0.00121	0.00129	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Etoposide—testicular cancer	0.00121	0.00128	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Ifosfamide—testicular cancer	0.0012	0.00128	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—testicular cancer	0.0012	0.00128	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Etoposide—testicular cancer	0.0012	0.00127	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Cisplatin—testicular cancer	0.0012	0.00127	CcSEcCtD
Hydroxychloroquine—Fatigue—Etoposide—testicular cancer	0.0012	0.00127	CcSEcCtD
Hydroxychloroquine—Pain—Etoposide—testicular cancer	0.00119	0.00126	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Methotrexate—testicular cancer	0.00118	0.00125	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Methotrexate—testicular cancer	0.00117	0.00124	CcSEcCtD
Hydroxychloroquine—Dizziness—Ifosfamide—testicular cancer	0.00116	0.00124	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00116	0.00123	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—testicular cancer	0.00115	0.00122	CcSEcCtD
Hydroxychloroquine—Nausea—Dactinomycin—testicular cancer	0.00114	0.00121	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Epirubicin—testicular cancer	0.00114	0.00121	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Etoposide—testicular cancer	0.00114	0.00121	CcSEcCtD
Hydroxychloroquine—Drowsiness—Doxorubicin—testicular cancer	0.00113	0.0012	CcSEcCtD
Hydroxychloroquine—Visual impairment—Methotrexate—testicular cancer	0.00113	0.0012	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00112	0.00119	CcSEcCtD
Hydroxychloroquine—Vomiting—Ifosfamide—testicular cancer	0.00112	0.00119	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Cisplatin—testicular cancer	0.00112	0.00119	CcSEcCtD
Hydroxychloroquine—Rash—Ifosfamide—testicular cancer	0.00111	0.00118	CcSEcCtD
Hydroxychloroquine—Dermatitis—Ifosfamide—testicular cancer	0.00111	0.00118	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Methotrexate—testicular cancer	0.00111	0.00118	CcSEcCtD
Hydroxychloroquine—Urticaria—Etoposide—testicular cancer	0.0011	0.00117	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Epirubicin—testicular cancer	0.0011	0.00117	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Etoposide—testicular cancer	0.0011	0.00117	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Etoposide—testicular cancer	0.0011	0.00117	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—testicular cancer	0.0011	0.00116	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methotrexate—testicular cancer	0.00109	0.00116	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—testicular cancer	0.00109	0.00116	CcSEcCtD
Hydroxychloroquine—Asthenia—Cisplatin—testicular cancer	0.00109	0.00116	CcSEcCtD
Hydroxychloroquine—Visual impairment—Epirubicin—testicular cancer	0.00106	0.00112	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—testicular cancer	0.00105	0.00112	CcSEcCtD
Hydroxychloroquine—Nausea—Ifosfamide—testicular cancer	0.00104	0.00111	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Cisplatin—testicular cancer	0.00104	0.0011	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Epirubicin—testicular cancer	0.00104	0.0011	CcSEcCtD
Hydroxychloroquine—Alopecia—Methotrexate—testicular cancer	0.00103	0.0011	CcSEcCtD
Hydroxychloroquine—Mental disorder—Methotrexate—testicular cancer	0.00103	0.00109	CcSEcCtD
Hydroxychloroquine—Eye disorder—Epirubicin—testicular cancer	0.00102	0.00109	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Etoposide—testicular cancer	0.00102	0.00109	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—testicular cancer	0.00102	0.00109	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methotrexate—testicular cancer	0.00102	0.00108	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—testicular cancer	0.00102	0.00108	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—testicular cancer	0.00101	0.00108	CcSEcCtD
Hydroxychloroquine—Asthenia—Etoposide—testicular cancer	0.000997	0.00106	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—INSL3—testicular cancer	0.000994	0.0169	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—KITLG—testicular cancer	0.000983	0.0167	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Etoposide—testicular cancer	0.000983	0.00104	CcSEcCtD
Hydroxychloroquine—Visual impairment—Doxorubicin—testicular cancer	0.000977	0.00104	CcSEcCtD
Hydroxychloroquine—Alopecia—Epirubicin—testicular cancer	0.000969	0.00103	CcSEcCtD
Hydroxychloroquine—Vomiting—Cisplatin—testicular cancer	0.000964	0.00102	CcSEcCtD
Hydroxychloroquine—Vision blurred—Methotrexate—testicular cancer	0.000961	0.00102	CcSEcCtD
Hydroxychloroquine—Mental disorder—Epirubicin—testicular cancer	0.00096	0.00102	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—testicular cancer	0.000959	0.00102	CcSEcCtD
Hydroxychloroquine—Rash—Cisplatin—testicular cancer	0.000956	0.00102	CcSEcCtD
Hydroxychloroquine—Dermatitis—Cisplatin—testicular cancer	0.000955	0.00101	CcSEcCtD
Hydroxychloroquine—Malnutrition—Epirubicin—testicular cancer	0.000954	0.00101	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Etoposide—testicular cancer	0.00095	0.00101	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—BCL10—testicular cancer	0.00095	0.0161	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Doxorubicin—testicular cancer	0.000948	0.00101	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—testicular cancer	0.000946	0.001	CcSEcCtD
Hydroxychloroquine—Anaemia—Methotrexate—testicular cancer	0.000942	0.001	CcSEcCtD
Hydroxychloroquine—Tension—Epirubicin—testicular cancer	0.000936	0.000995	CcSEcCtD
Hydroxychloroquine—Nervousness—Epirubicin—testicular cancer	0.000927	0.000985	CcSEcCtD
Hydroxychloroquine—Dizziness—Etoposide—testicular cancer	0.000919	0.000976	CcSEcCtD
Hydroxychloroquine—Vertigo—Methotrexate—testicular cancer	0.000916	0.000973	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methotrexate—testicular cancer	0.000913	0.00097	CcSEcCtD
Hydroxychloroquine—Nausea—Cisplatin—testicular cancer	0.000901	0.000957	CcSEcCtD
Hydroxychloroquine—Vision blurred—Epirubicin—testicular cancer	0.000899	0.000955	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—testicular cancer	0.000896	0.000952	CcSEcCtD
Hydroxychloroquine—Mental disorder—Doxorubicin—testicular cancer	0.000888	0.000944	CcSEcCtD
Hydroxychloroquine—Convulsion—Methotrexate—testicular cancer	0.000883	0.000939	CcSEcCtD
Hydroxychloroquine—Vomiting—Etoposide—testicular cancer	0.000883	0.000938	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—testicular cancer	0.000883	0.000938	CcSEcCtD
Hydroxychloroquine—Anaemia—Epirubicin—testicular cancer	0.000882	0.000937	CcSEcCtD
Hydroxychloroquine—Agitation—Epirubicin—testicular cancer	0.000877	0.000932	CcSEcCtD
Hydroxychloroquine—Rash—Etoposide—testicular cancer	0.000876	0.000931	CcSEcCtD
Hydroxychloroquine—Dermatitis—Etoposide—testicular cancer	0.000875	0.00093	CcSEcCtD
Hydroxychloroquine—Headache—Etoposide—testicular cancer	0.00087	0.000925	CcSEcCtD
Hydroxychloroquine—Tension—Doxorubicin—testicular cancer	0.000866	0.00092	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000862	0.000916	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—testicular cancer	0.000857	0.000911	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—testicular cancer	0.000857	0.000911	CcSEcCtD
Hydroxychloroquine—Leukopenia—Epirubicin—testicular cancer	0.000854	0.000907	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Epirubicin—testicular cancer	0.000839	0.000891	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—testicular cancer	0.000832	0.000884	CcSEcCtD
Hydroxychloroquine—Convulsion—Epirubicin—testicular cancer	0.000827	0.000878	CcSEcCtD
Hydroxychloroquine—Nausea—Etoposide—testicular cancer	0.000825	0.000877	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—testicular cancer	0.000816	0.000867	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—testicular cancer	0.000816	0.000867	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—testicular cancer	0.000815	0.000866	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—testicular cancer	0.000811	0.000862	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methotrexate—testicular cancer	0.000808	0.000859	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000807	0.000857	CcSEcCtD
Hydroxychloroquine—Vertigo—Doxorubicin—testicular cancer	0.000793	0.000843	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—testicular cancer	0.000793	0.000843	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—testicular cancer	0.00079	0.00084	CcSEcCtD
Hydroxychloroquine—Oedema—Epirubicin—testicular cancer	0.000779	0.000827	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—KITLG—testicular cancer	0.000777	0.0132	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—testicular cancer	0.000776	0.000824	CcSEcCtD
Hydroxychloroquine—Convulsion—Doxorubicin—testicular cancer	0.000765	0.000813	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Epirubicin—testicular cancer	0.000764	0.000811	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—testicular cancer	0.000762	0.00081	CcSEcCtD
Hydroxychloroquine—Skin disorder—Epirubicin—testicular cancer	0.000756	0.000804	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—BCL10—testicular cancer	0.000751	0.0128	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000746	0.000793	CcSEcCtD
Hydroxychloroquine—Anorexia—Epirubicin—testicular cancer	0.000742	0.000789	CcSEcCtD
Hydroxychloroquine—Somnolence—Methotrexate—testicular cancer	0.00074	0.000786	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—FGFR3—testicular cancer	0.000731	0.0124	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Methotrexate—testicular cancer	0.000723	0.000769	CcSEcCtD
Hydroxychloroquine—Oedema—Doxorubicin—testicular cancer	0.000721	0.000766	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000718	0.000763	CcSEcCtD
Hydroxychloroquine—Fatigue—Methotrexate—testicular cancer	0.000717	0.000762	CcSEcCtD
Hydroxychloroquine—Pain—Methotrexate—testicular cancer	0.000712	0.000756	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—testicular cancer	0.000707	0.000751	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000705	0.00075	CcSEcCtD
Hydroxychloroquine—Skin disorder—Doxorubicin—testicular cancer	0.0007	0.000744	CcSEcCtD
Hydroxychloroquine—Somnolence—Epirubicin—testicular cancer	0.000692	0.000736	CcSEcCtD
Hydroxychloroquine—Anorexia—Doxorubicin—testicular cancer	0.000687	0.00073	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00068	0.000723	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Epirubicin—testicular cancer	0.000677	0.000719	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000672	0.000714	CcSEcCtD
Hydroxychloroquine—Fatigue—Epirubicin—testicular cancer	0.000671	0.000713	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KIT—testicular cancer	0.000671	0.0114	CbGpPWpGaD
Hydroxychloroquine—Pain—Epirubicin—testicular cancer	0.000666	0.000708	CcSEcCtD
Hydroxychloroquine—Urticaria—Methotrexate—testicular cancer	0.000661	0.000702	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methotrexate—testicular cancer	0.000658	0.000699	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—testicular cancer	0.000658	0.000699	CcSEcCtD
Hydroxychloroquine—Somnolence—Doxorubicin—testicular cancer	0.000641	0.000681	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000637	0.000677	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Doxorubicin—testicular cancer	0.000626	0.000666	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000622	0.000661	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—testicular cancer	0.000621	0.00066	CcSEcCtD
Hydroxychloroquine—Urticaria—Epirubicin—testicular cancer	0.000619	0.000657	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—testicular cancer	0.000616	0.000655	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—testicular cancer	0.000616	0.000654	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—testicular cancer	0.000616	0.000654	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Methotrexate—testicular cancer	0.000613	0.000651	CcSEcCtD
Hydroxychloroquine—Asthenia—Methotrexate—testicular cancer	0.000597	0.000634	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000589	0.000626	CcSEcCtD
Hydroxychloroquine—Pruritus—Methotrexate—testicular cancer	0.000589	0.000626	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—FGFR3—testicular cancer	0.000578	0.00982	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Epirubicin—testicular cancer	0.000574	0.00061	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—KITLG—testicular cancer	0.000573	0.00973	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Doxorubicin—testicular cancer	0.000572	0.000608	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Doxorubicin—testicular cancer	0.00057	0.000605	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—testicular cancer	0.00057	0.000605	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Methotrexate—testicular cancer	0.000569	0.000605	CcSEcCtD
Hydroxychloroquine—Asthenia—Epirubicin—testicular cancer	0.000559	0.000594	CcSEcCtD
Hydroxychloroquine—Pruritus—Epirubicin—testicular cancer	0.000551	0.000585	CcSEcCtD
Hydroxychloroquine—Dizziness—Methotrexate—testicular cancer	0.00055	0.000585	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Epirubicin—testicular cancer	0.000533	0.000566	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—testicular cancer	0.000531	0.000564	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—KIT—testicular cancer	0.00053	0.00901	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Methotrexate—testicular cancer	0.000529	0.000562	CcSEcCtD
Hydroxychloroquine—Rash—Methotrexate—testicular cancer	0.000525	0.000557	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—testicular cancer	0.000524	0.000557	CcSEcCtD
Hydroxychloroquine—Headache—Methotrexate—testicular cancer	0.000521	0.000554	CcSEcCtD
Hydroxychloroquine—Asthenia—Doxorubicin—testicular cancer	0.000517	0.000549	CcSEcCtD
Hydroxychloroquine—Dizziness—Epirubicin—testicular cancer	0.000515	0.000547	CcSEcCtD
Hydroxychloroquine—Pruritus—Doxorubicin—testicular cancer	0.00051	0.000542	CcSEcCtD
Hydroxychloroquine—Vomiting—Epirubicin—testicular cancer	0.000495	0.000526	CcSEcCtD
Hydroxychloroquine—Nausea—Methotrexate—testicular cancer	0.000494	0.000525	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Doxorubicin—testicular cancer	0.000493	0.000524	CcSEcCtD
Hydroxychloroquine—Rash—Epirubicin—testicular cancer	0.000491	0.000522	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—testicular cancer	0.000491	0.000521	CcSEcCtD
Hydroxychloroquine—Headache—Epirubicin—testicular cancer	0.000488	0.000518	CcSEcCtD
Hydroxychloroquine—Dizziness—Doxorubicin—testicular cancer	0.000476	0.000506	CcSEcCtD
Hydroxychloroquine—Nausea—Epirubicin—testicular cancer	0.000463	0.000491	CcSEcCtD
Hydroxychloroquine—Vomiting—Doxorubicin—testicular cancer	0.000458	0.000487	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	0.000458	0.00778	CbGpPWpGaD
Hydroxychloroquine—Rash—Doxorubicin—testicular cancer	0.000454	0.000483	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—testicular cancer	0.000454	0.000482	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—KITLG—testicular cancer	0.000453	0.00769	CbGpPWpGaD
Hydroxychloroquine—Headache—Doxorubicin—testicular cancer	0.000451	0.00048	CcSEcCtD
Hydroxychloroquine—Nausea—Doxorubicin—testicular cancer	0.000428	0.000455	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—FGFR3—testicular cancer	0.000426	0.00723	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KIT—testicular cancer	0.000391	0.00664	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FGFR3—testicular cancer	0.000336	0.00572	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—H2AFZ—testicular cancer	0.000318	0.00541	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STK11—testicular cancer	0.000316	0.00538	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KIT—testicular cancer	0.000309	0.00525	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KITLG—testicular cancer	0.000293	0.00497	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGFR3—testicular cancer	0.000218	0.0037	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KIT—testicular cancer	0.0002	0.00339	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HPGDS—testicular cancer	7.83e-05	0.00133	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—STK11—testicular cancer	5.69e-05	0.000967	CbGpPWpGaD
